PTC Therapeutics (NasdaqGS:PTCT) Q2 2026 Earnings call July 30, 2026 04:30 PM ET Company ParticipantsEllen Cavaleri - Head of Investor RelationsMatthew Klein - CEOEric Pauwels - Chief Business OfficerPierre Gravier - CFOConference Call ParticipantsKristen Kluska - AnalystTazeen Ahmad - AnalystNone - AnalystEric Joseph - AnalystBen Burnett - AnalystBrian Cheng - AnalystJudah Frommer - AnalystJoseph Thome - AnalystFaisal Khurshid - AnalystNone - AnalystLuke Herrmann - AnalystJoseph Schwartz - AnalystPaul Choi ...